Aspirin cardiovascular use labeling should advise physician consultation -- McNeil.
This article was originally published in The Tan Sheet
Executive Summary
ASPIRIN LABEL WITH PHYSICIAN CONSULTATION INSTRUCTIONS FOR CARDIOVASCULAR USERS suggested by McNeil Consumer Products in April 14 comments to FDA. McNeil, the maker of Tylenol brand acetaminophen, says in the letter that "consumer labeling for aspirin should advise patients taking low-dose aspirin under their physician's care for cardiovascular indications to consult with their physician on appropriate analgesic or antipyretic use."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning